Supply of specified parenteral and intramuscular drugs
Original notice title
Suministro de medicamentos con principios activos dexclorfeniramina parenteral, foscarnet, micafungina, tigeciclina, paracetamol parenteral, paliperidona intramuscular, fentanilo parenteral y vancomicina parenteral para los centros dependientes del servicio murciano de salud.
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
Procurement documents are not analyzed; essential details (technical specs, eligibility conditions, evaluation methodol...
Award criteria are described only as 'quality' with a points system, but the breakdown between price and technical fact...
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 7.3M estimated value
- Supplies contract
- 3 lots
- Duration 2 YEAR
- Supply of pharmaceutical products (active substances: dexchlorpheniramine, foscarnet, micafungin, tigecycline, paracetamol, paliperidone, fentanyl, vancomycin) to health centers dependent on the Murcia Health Service.
- Duration: 2 years, with 2 possible one-year extensions.
Show full summary
This is an open tender by the Servicio Murciano de Salud (Murcia Health Service) for the supply of multiple pharmaceutical products to its health centers. It includes 8 lots covering parenteral dexchlorpheniramine, foscarnet, micafungin, tigecycline, paracetamol, paliperidone, fentanyl, and vancomycin. The contract duration is 2 years with possible 2-year extensions. The total estimated value is €7,254,280. Electronic submission is required, and the procedure is conducted in Spanish. Award criteria are quality-based with a maximum of 100 points, but detailed evaluation weights are not specified. Procurement documents are not fully analyzed, and eligibility criteria are generic. The tender notice is a correction (version 1) published on 2026-06-02; deadline for submission is 2026-07-03.
Risks
Procurement documents are not analyzed; essential details (technical specs, eligibility conditions, evaluation methodol...
Award criteria are described only as 'quality' with a points system, but the breakdown between price and technical fact...
Submission deadline in 9 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure.
Administrative
- Electronic submission required.
- Submission language: Spanish (SPA).
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Lot 8
Buyer
Name
Servicio Murciano de Salud - Junta de Compras
Location
Espinardo, ESP
Buyer profile
Identifier
41261690169929
Lots (8)
LOT-0001
dexclorfeniramina 5 mg via intravenosa
Supply of dexchlorpheniramine 5 mg intravenous formulation for 2 years, with options for 2 yearly extensions.
EUR 330k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
dexclorfeniramina 5 mg via intravenosa
LOT-0002
foscarnet 6.000 mg (24mg/ml) via intravenosa
Supply of foscarnet 6000 mg (24 mg/ml) intravenous formulation for 2 years, with options for 2 yearly extensions.
EUR 114k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
foscarnet 6.000 mg (24mg/ml) via intravenosa
LOT-0003
micafungina 100 mg intravenosa,micafungina 50 mg intravenosa
Supply of micafungin 100 mg and 50 mg intravenous formulations for 2 years, with options for 2 yearly extensions.
EUR 340.8k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
micafungina 100 mg intravenosa,micafungina 50 mg intravenosa
LOT-0004
tigeciclina 50 mg via intravenosa
tigeciclina 50 mg via intravenosa
EUR 92.4k
Estimated value
Location
Duration
Category
Selection criteria
Award details
LOT-0005
paracetamol 10 mg/ml 100 ml
paracetamol 10 mg/ml 100 ml
EUR 2.7M
Estimated value
Location
Duration
Category
Selection criteria
Award details
LOT-0006
paliperidona intramuscular mensual (todas las presentaciones disponibles)
paliperidona intramuscular mensual (todas las presentaciones disponibles)
EUR 2.9M
Estimated value
Location
Duration
Category
Selection criteria
Award details
LOT-0007
fentanilo 0,05 mg/ml amp 3 ml
fentanilo 0,05 mg/ml amp 3 ml
EUR 420.6k
Estimated value
Location
Duration
Category
Selection criteria
Award details
LOT-0008
vancomicina 500 mg vial, vancomicina 1g vial
vancomicina 500 mg vial, vancomicina 1g vial
EUR 399.3k
Estimated value
Location
Duration
Category
Selection criteria
Award details
Procurement Details
- Publication date
- 02 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Spanish
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 379718-2026
- Source notice ID
- 078f55ce-f40f-477c-9913-5a56dbecc4ac
Documents (1)
Similar tenders
Poland – Various medicinal products – ZP.220.99.26 Dostawa różnych produktów leczniczych, żywności medycznej oraz preparatów do żywienia pacjentów na potrzeby
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antithrombotic agents – Dostawa produktów leczniczych do leczenia zaburzeń w funkcjonowaniu przewodu pokarmowego, środków antybakteryjnych do użytku ogólnoustrojowego (...) w podziale na 21 części.
Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM
Czechia – Antibacterials for systemic use – Léčivé přípravky s obsahem kolistinu
Romania – Various medicinal products – ACORD CADRU FURNIZARE MEDICAMENTE SI SOLUTII PERFUZABILE 24 LUNI
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
Procurement documents are not analyzed; essential details (technical specs, eligibility conditions, evaluation methodol...
Award criteria are described only as 'quality' with a points system, but the breakdown between price and technical fact...
Submission deadline in 9 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications